About Protein DDI1 homolog 1
Protein DDI1 homolog 1 (DDI1) is a protein
from Homo sapiens identified by UniProt accession
Q8WTU0, 396 residues long.
MolForge cross-references it against 0 known binders and
60 disease associations.
Target properties
| Protein name | Protein DDI1 homolog 1 |
| UniProt accession | Q8WTU0 |
| Gene | DDI1 |
| Organism | Homo sapiens |
| Length | 396 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (60)
Diseases linked to this target (Open Targets).
- angina pectoris · score 0.22
- coronary artery disease · score 0.21
- high density lipoprotein cholesterol measurement · score 0.19
- myocardial infarction · score 0.18
- pulse pressure measurement · score 0.17
- Vasodilators used in cardiac diseases use measurement · score 0.16
- low density lipoprotein cholesterol measurement · score 0.16
- carotid artery intima media thickness · score 0.16
- PHF-tau measurement · score 0.13
- adrenal suppression measurement · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WTU0-F1 | alphafold | PREDICTED | 77.53 | — |
Amino-acid sequence (396 residues)
MLITVYCVRR DLSEVTFSLQ VSPDFELRNF KVLCEAESRV PVEEIQIIHM ERLLIEDHCS LGSYGLKDGD IVVLLQKDNV GPRAPGRAPN QPRVDFSGIA VPGTSSSRPQ HPGQQQQRTP AAQRSQGLAS GEKVAGLQGL GSPALIRSML LSNPHDLSLL KERNPPLAEA LLSGSLETFS QVLMEQQREK ALREQERLRL YTADPLDREA QAKIEEEIRQ QNIEENMNIA IEEAPESFGQ VTMLYINCKV NGHPLKAFVD SGAQMTIMSQ ACAERCNIMR LVDRRWAGVA KGVGTQRIIG RVHLAQIQIE GDFLQCSFSI LEDQPMDMLL GLDMLRRHQC SIDLKKNVLV IGTTGTQTYF LPEGELPLCS RMVSGQDESS DKEITHSVMD SGRKEH
Explore Protein DDI1 homolog 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets